Chronic News and Research

RSS

OPA encourages Ontarians to discuss travel-related health questions with their pharmacists

Every spring, thousands of Ontarians embark on vacations and, along with luggage and family members, many bring medication. While your passport and camera may seem like the most important things to remember, ensuring you have a backup supply of your prescription medication should be at the top of your to-do list as well.

1 Mar 2010

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.

1 Mar 2010

Alere Health's chief officer to discuss factors essential to create most effective health ecosystem

Noting that most people are struggling with information overload and confusion when it comes to the nation's disparate and complex healthcare system, Gordon Norman, M.D., chief innovation officer for Alere Health, LLC, will highlight a range of attainable solutions at the 10th annual Population Health & Disease Management Colloquium to be held February 28 – March 2 in Philadelphia.

1 Mar 2010

JACI supplement supports the importance of small airways in asthma management

Increasing evidence supports the importance of small airways in the diagnosis and treatment of asthma; however, focused areas of discussion and critical review of this topic have been lacking. To foster a better understanding of the role of small airways in asthma management, Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd., will be providing reprints of a special supplement entitled "Small Airway Involvement: A Key to Asthma" from the December issue of the Journal of Allergy and Clinical Immunology at their exhibit (Booth #724) at the American Academy of Allergy, Asthma & Immunology Annual Meeting being held Feb. 26-March 2, 2010 in New Orleans, La.

1 Mar 2010

Using genetic engineering techniques in pigs, scientists create new model of diabetes

The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.

1 Mar 2010

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).

1 Mar 2010

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in the March issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

1 Mar 2010

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.

1 Mar 2010

Precise immune disturbances leading to Coeliac disease: More insight

New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified. These latest findings could speed the way towards improved diagnostics and treatments for the autoimmune complaint that affects 1 in 100 of the population, and lead to insights into related conditions such as type 1 diabetes.

28 Feb 2010

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Republicans and Democrat hit the Sunday talk shows today to debate whether a complex congressional process called 'reconciliation' should be used to consider a major overhaul of the U.S. health care system. Reconciliation is normally used for 'taxing and spending and reducing deficits,' said Sen.

28 Feb 2010

Of the 2.3M inmates, only 1.5M meet DSM IV medical criteria for substance abuse: CASA

Of the 2.3 million inmates crowding our nation's prisons and jails, 1.5 million meet the DSM IV medical criteria for substance abuse or addiction, and another 458,000, while not meeting the strict DSM IV criteria, had histories of substance abuse; were under the influence of alcohol or other drugs at the time of their crime; committed their offense to get money to buy drugs; were incarcerated for an alcohol or drug law violation; or shared some combination of these characteristics, according to Behind Bars II: Substance Abuse and America's Prison Population. Combined these two groups constitute 85 percent of the U.S. prison population.

27 Feb 2010

Widespread cases of flu plunge from 49 to zero

Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year.

27 Feb 2010

Single submission of orphan drug designation annual report for both FDA and EMA

In recognition of World Rare Disease Day, the U.S. Food and Drug Administration and the European Medicines Agency (EMA) today announced a more streamlined process to help regulators better identify and share information throughout the development process of orphan drug and biologic products, which are developed specifically to treat rare medical conditions. Both agencies have agreed to accept the submission of a single annual report from sponsors of orphan drug and biologic products designated by both the United States and the European Union.

27 Feb 2010

Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares

Midlothian Laboratories, a division of Hi-Tech Pharmacal Co., Inc., as part of its continuing humanitarian relief efforts, recently donated more than $3 million worth of essential vitamins and nutritional supplements to AmeriCares for people in the developing world living in extreme poverty and suffering from chronic malnutrition.

27 Feb 2010

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

High-intensity, repetitive rehabilitation exercises can help stroke survivors significantly improve functioning in their paralyzed arm and in their quality of life — even years after their disabling event, according to late-breaking science results presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

State roundup: S.C. plan would end benefits to 30,000 disabled residents; Judge bars Calif. from cutting elderly from day care; Mass. faces lawsuit on immigrant health care

Children with autism, people with spine and brain injuries and the long-term disabled in job programs are among the 30,000 people who would lose state help under a $5.1 billion spending plan approved by a House committee Thursday.

27 Feb 2010

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia.

27 Feb 2010

Colorado city a model for low-cost, high quality care, series details

Colorado Public News/Los Angeles Times presents a series of stories about Grand Junction Colorado which delivers some of the best and lowest-cost health care in the nation.

26 Feb 2010

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Wound Management Technologies, Inc. announced today that the recent increase in sales activities throughout the United States has resulted in 45 new clinicians evaluating their advanced wound care collagen product, CellerateRx® . In the last two months, these evaluations have transpired into new customers in Arizona, New Mexico, South Carolina, North Dakota, New Jersey, Wyoming, Colorado, and New York.

26 Feb 2010

New strategy against Botulinum toxin

A study involving the world's deadliest substance has yielded a new strategy to clear toxins from the body-which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases.

26 Feb 2010

Chronic News and Research

OPA encourages Ontarians to discuss travel-related health questions with their pharmacists

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

Alere Health's chief officer to discuss factors essential to create most effective health ecosystem

JACI supplement supports the importance of small airways in asthma management

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Precise immune disturbances leading to Coeliac disease: More insight

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Of the 2.3M inmates, only 1.5M meet DSM IV medical criteria for substance abuse: CASA

Widespread cases of flu plunge from 49 to zero

Single submission of orphan drug designation annual report for both FDA and EMA

Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares

Chronic stroke impairment: Intensive, repetitive rehabilitation exercises may benefit arms, legs and cognitive function

State roundup: S.C. plan would end benefits to 30,000 disabled residents; Judge bars Calif. from cutting elderly from day care; Mass. faces lawsuit on immigrant health care

Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells

Colorado city a model for low-cost, high quality care, series details

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

New strategy against Botulinum toxin

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News